Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (SVE) Revenue
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Revenue
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. had a revenue of 12.85M in the quarter ending Jun 30, 2026, with -5.58%. This bring the company's revenue in the last twelve months to 48.76M, Increased 15.56%. In the fiscal year ending Dec 31, 2025, Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. had annual revenue of 42.01M with -41.46% growth.
- Revenue (ttm)
- 48.76M
- Revenue Growth
- -21.82%
- P/S Ratio
- 4.78
- Revenue/Employee
- PLN 196,304
- Employees
- 214
- Market Cap
- PLN 200.69M
Revenue Chart
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 42.01M | -29.75M | -41.46% |
| Dec 31, 2024 | 71.76M | 13.15M | 22.44% |
| Dec 31, 2023 | 58.61M | 8.22M | 16.32% |
| Dec 31, 2022 | 50.38M | 9.23M | 22.43% |
| Dec 31, 2021 | 41.15M | 995.00K | 2.48% |
| Dec 31, 2020 | 40.16M | 1.05M | 2.69% |
| Dec 31, 2019 | 39.11M | 6.81M | 21.10% |
| Dec 31, 2018 | 32.29M | 889.00K | 2.83% |
| Dec 31, 2017 | 31.40M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| PL:SVE | 48.76M |